bpc-157 clinical trials humans tendon healing Regeneration or Risk? A Narrative Review of for Musculoskeletal How BPC-157 Accelerates Tissue Regeneration
Description
Standard dosing protocol: Dose: 250-500mcg per injection Frequency: Twice daily (morning and evening) Duration: 4-8 weeks depending on injury severity Injection site: As close to injury as safely possible Weight-based dosing: Some people dose by body weight: 2.5-4 mcg per kilogram
Intrinsic Anticonvulsant Activity BPC-157 demonstrated anticonvulsant activity across multiple convulsant models
WADA 2026 Prohibited List Status (Section S0) BPC-157 is named explicitly on the World Anti-Doping Agency 2025 and 2026 Prohibited Lists under section S0 (Non-Approved Substances)
It also stimulates focal adhesion kinase (FAK)-paxillin complexes, which help cells migrate and attach during tissue reconstruction
Research Use Only Glow Blend (GHK-Cu, BPC-157, TB-500) has not been evaluated by the FDA for safety or efficacy in humans
